JP2009545526A5 - - Google Patents

Download PDF

Info

Publication number
JP2009545526A5
JP2009545526A5 JP2009520801A JP2009520801A JP2009545526A5 JP 2009545526 A5 JP2009545526 A5 JP 2009545526A5 JP 2009520801 A JP2009520801 A JP 2009520801A JP 2009520801 A JP2009520801 A JP 2009520801A JP 2009545526 A5 JP2009545526 A5 JP 2009545526A5
Authority
JP
Japan
Prior art keywords
iodo
rgia
glu14
peia
tyr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009520801A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009545526A (ja
JP5558817B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/016163 external-priority patent/WO2008011006A2/en
Publication of JP2009545526A publication Critical patent/JP2009545526A/ja
Publication of JP2009545526A5 publication Critical patent/JP2009545526A5/ja
Application granted granted Critical
Publication of JP5558817B2 publication Critical patent/JP5558817B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009520801A 2006-07-18 2007-07-17 痛みの処置方法および鎮痛化合物のスクリーニング方法 Expired - Fee Related JP5558817B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83146806P 2006-07-18 2006-07-18
US60/831,468 2006-07-18
PCT/US2007/016163 WO2008011006A2 (en) 2006-07-18 2007-07-17 Methods for treating pain and screening analgesic compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014116680A Division JP5953338B2 (ja) 2006-07-18 2014-06-05 痛みの処置方法および鎮痛化合物のスクリーニング方法

Publications (3)

Publication Number Publication Date
JP2009545526A JP2009545526A (ja) 2009-12-24
JP2009545526A5 true JP2009545526A5 (https=) 2010-09-02
JP5558817B2 JP5558817B2 (ja) 2014-07-23

Family

ID=38957314

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009520801A Expired - Fee Related JP5558817B2 (ja) 2006-07-18 2007-07-17 痛みの処置方法および鎮痛化合物のスクリーニング方法
JP2014116680A Expired - Fee Related JP5953338B2 (ja) 2006-07-18 2014-06-05 痛みの処置方法および鎮痛化合物のスクリーニング方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014116680A Expired - Fee Related JP5953338B2 (ja) 2006-07-18 2014-06-05 痛みの処置方法および鎮痛化合物のスクリーニング方法

Country Status (6)

Country Link
US (1) US9717775B2 (https=)
EP (1) EP2051726B1 (https=)
JP (2) JP5558817B2 (https=)
AU (1) AU2007275764B2 (https=)
CA (1) CA2657532C (https=)
WO (1) WO2008011006A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5558817B2 (ja) 2006-07-18 2014-07-23 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション 痛みの処置方法および鎮痛化合物のスクリーニング方法
US9284358B2 (en) * 2006-07-18 2016-03-15 University Of Utah Research Foundation Conotoxin peptides
CN105377286B (zh) 2013-05-31 2021-07-02 犹他大学研究基金会 芋螺毒素(conotoxin)肽，其医药组合物和用途
KR102170077B1 (ko) * 2018-05-21 2020-10-27 인하대학교 산학협력단 Prss14/st14의 자가분해 고리부분을 특이적으로 인식하는 단일클론항체 및 이의 용도
WO2020138948A2 (ko) * 2018-12-26 2020-07-02 아미코젠주식회사 아세틸콜린 수용체 저해 펩타이드 및 이의 용도
CR20210363A (es) * 2019-01-04 2021-12-10 Kineta Chronic Pain Llc Análogos de péptidos de canotoxina y usos para el tratamiento del dolor y de las afecciones inflamatorias
US11612661B2 (en) 2019-01-04 2023-03-28 Kineta Chronic Pain, Llc Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditions
EP3969468A1 (en) * 2019-05-17 2022-03-23 Janssen Pharmaceutica NV Expression systems for the alpha 9/alpha 10 nicotinic acetylcholine receptor and methods of use thereof
CN113493502B (zh) * 2020-04-01 2023-09-12 广西大学 α-芋螺毒素肽TxIE、其药物组合物及用途
JP7715435B2 (ja) * 2021-07-27 2025-07-30 スキンメドカンパニーリミテッド アセチルコリン受容体結合最適化短縮ペプチド及びその用途

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4353888A (en) 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4883666A (en) 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US5158881A (en) 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
DE3829752A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration
DE3829766A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Verfahren zur herstellung von membranen
US5082670A (en) 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5618531A (en) 1990-10-19 1997-04-08 New York University Method for increasing the viability of cells which are administered to the brain or spinal cord
CA2109085C (en) 1991-04-25 2003-03-11 Keith E. Dionne Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
US5854217A (en) 1992-09-28 1998-12-29 Bearsden Bio, Inc. Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
ATE190633T1 (de) 1993-04-27 2000-04-15 Cytotherapeutics Inc Membran aus einem acrylnitrilpolymer
AU688776B2 (en) 1993-06-23 1998-03-19 Brown University Research Foundation Method and apparatus for sealing implantable, membrane encapsulation devices
ATE218893T1 (de) 1993-08-12 2002-06-15 Neurotech Sa Biokompatible immunoisolatorische kapseln, die genetisch veränderte zellen enthalten
US5550050A (en) 1994-04-15 1996-08-27 Cytotherapeutics, Inc. Method for implanting encapsulated cells in a host
US5840576A (en) 1994-07-20 1998-11-24 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5834029A (en) 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
IN181898B (https=) 1995-06-07 1998-10-24 Cytotherapeutics Inc
US5837234A (en) 1995-06-07 1998-11-17 Cytotherapeutics, Inc. Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
AU7204996A (en) 1995-10-02 1997-04-28 Cytotherapeutics, Inc. Method for treating amyotrophic lateral sclerosis
AU2430897A (en) * 1996-03-26 1997-10-17 Regents Of The University Of California, The Selective target cell activation by expression of a g protein-coupled receptor activated superiorly by synthetic ligand
US5844077A (en) 1997-04-28 1998-12-01 Cytotherapeutics, Inc. Use of conantokins for producing analgesia or for neuroprotection
WO1999033482A1 (en) * 1997-12-31 1999-07-08 University Of Utah Research Foundation Uses of alpha-conotoxin peptides
JP2002534996A (ja) 1999-01-29 2002-10-22 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション アルファ−コノトキシン・ペプチド
AU3473800A (en) * 1999-01-29 2000-08-18 University Of Utah Research Foundation Conotoxin peptides
AU780460B2 (en) 1999-09-15 2005-03-24 Janssen Pharmaceutica N.V. Nicotinic acetylcholine receptor alpha10 subunit
EP1090991A1 (en) * 1999-09-29 2001-04-11 Sanofi-Synthelabo Novel nicotinic acetylcholine receptor subunit, its isolation and use
WO2002064740A2 (en) * 2001-02-09 2002-08-22 Cognetix, Inc. Cone snail peptides
AUPR409401A0 (en) 2001-03-29 2001-04-26 University Of Melbourne, The Analgesic compound
EP1919506A1 (en) * 2005-08-02 2008-05-14 Metabolic Pharmaceuticals Ltd. Peptide conjugate for oral delivery of hydrophilic peptide analgesics
AU2006236006B2 (en) * 2006-04-13 2012-09-06 The University Of Queensland Cyclised a-conotoxin peptides
JP5558817B2 (ja) * 2006-07-18 2014-07-23 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション 痛みの処置方法および鎮痛化合物のスクリーニング方法
US9284358B2 (en) 2006-07-18 2016-03-15 University Of Utah Research Foundation Conotoxin peptides

Similar Documents

Publication Publication Date Title
JP2009545526A5 (https=)
Rothenberg et al. Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis
JP2015501297A5 (ja) 医薬組成物、方法、診断キット
JP2018529698A5 (https=)
JP2007529204A5 (https=)
JP2011528896A5 (https=)
NZ617196A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
JP2011528895A5 (https=)
JP2016539156A5 (https=)
JP2008536483A5 (https=)
JP2009544630A5 (https=)
JP2009543567A5 (https=)
CA2442909A1 (en) Multimerization of hiv-1 vif protein as a therapeutic target
JP2017113019A5 (https=)
JP2019510739A5 (https=)
JP2011528897A5 (https=)
HRP20161458T1 (hr) Polipeptidi, polinukleotidi i pripravci namijenjeni upotrebi u liječenju latentne tuberkuloze
HRP20171694T1 (hr) Novi pripravci i postupci
JP2016540729A5 (https=)
JP2011505414A5 (https=)
JP2006506942A5 (https=)
JP2008517900A5 (https=)
Bronowicki et al. Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C
Rakugi et al. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study
JP2017519762A5 (https=)